03:13:06 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



CGI Inc
Symbol GIB
Shares Issued 206,234,090
Close 2024-01-19 C$ 145.84
Market Cap C$ 30,077,179,686
Recent Sedar Documents

CGI, Korber partner to improve pharma production

2024-01-22 09:57 ET - News Release

Mr. Tim Hurlebaus reports

CGI AND KORBER ANNOUNCE GLOBAL PARTNERSHIP TO ENABLE PHARMACEUTICAL AND LIFE SCIENCES CLIENTS TO IMPROVE PRODUCTION OPERATIONS

CGI Inc. has entered into a partnership with Korber, aimed at enabling pharmaceutical and life sciences companies to improve their production processes by combining CGI's end-to-end services with Korber's Werum PAS-X manufacturing execution system (MES) suite. The global partnership is designed to help clients increase efficiency, accuracy and safety in pharma products, and enhance decision-making through access to real-time data.

"CGI works side-by-side with clients to transform data into actionable insights to drive smart, sustainable and resilient operations," said Tim Hurlebaus, president, United States commercial and state government operations, and global executive sponsor for CGI's health and life sciences business. "This includes combining the benefits of MES and industry 5.0 to gather rich insights to enable operational excellence. Our partnership with Korber complements our offerings portfolio, enabling us to deliver innovative new services and solutions to support the needs of our pharma and life sciences clients."

Korber's platform serves as a digital, real-time process controller to shorten time to market, lower production costs and enable a more patient-centric approach, improving outcomes and leading to improved health. Compliant with good manufacturing practices, PAS-X MES presents a comprehensive view of data from diverse integrated systems, enabling faster and more informed decisions, which can be a critical advantage in an industry where timing and accuracy are paramount.

"Our PAS-X products and service suites facilitate seamless digital transformation projects at our customers globally. By combining forces with CGI's global presence, expertise and complementary service portfolio in pharma and life sciences, we can offer a unique and compelling value proposition. CGI is one of the key partners to continue to expand our offering to our global customers," says Jan-Henrik Dieckert, chief operating office, software, Korber business area pharma.

Embedding robust IT (information technology) and operational technology (OT) security, CGI's business consulting and MES services expertise enables faster, more seamless and operationally integrated implementation of the platform, including transformation through technical integration, data migration, and organizational change management and adoption.

"In our global client insights research, pharma and life sciences executives said optimizing operations is their top business priority. CGI serves as a trusted adviser to help them achieve this priority through ROI [return on investment]-led digitization investments," said Maiken Lykke, senior vice-president, CGI Denmark. "We work collaboratively with clients to build solutions that tailor the right mix of services and technologies for their needs. We are pleased to partner with Korber to address the unique client challenges in this industry."

CGI delivers clinical and IT solutions for 11 of the top-20 global biotech and pharmaceutical companies, including helping these organizations optimize their processes, launch new therapies for cancer and rare diseases, and drive digital transformation across their research and development, manufacturing and commercial functions, globally.

About CGI Inc.

Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 91,500 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI fiscal 2023 reported revenue is $14.30-billion and CGI shares are listed on the Toronto Stock Exchange (GIB.A) and the New York Stock Exchange (GIB).

About Korber

Korber is an international technology group with more than 12,000 employees at over 100 locations worldwide. The company's goal is to turn entrepreneurial thinking into customer success and shape technological change. In the digital, pharma, supply chain and technologies business areas, the company offers products, solutions and services that inspire. Korber acts fast to customer needs, executes ideas seamlessly and, with its innovations, creates added value for its customers. In doing so, Korber is increasingly building on ecosystems that solve the challenges of today and tomorrow. Korber AG is the holding company of the Korber Group.

© 2024 Canjex Publishing Ltd. All rights reserved.